Comprehensive study to examine the effects of omalizumab in patients with bronchial asthma.

Trial Profile

Comprehensive study to examine the effects of omalizumab in patients with bronchial asthma.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Apr 2016

At a glance

  • Drugs Omalizumab (Primary)
  • Indications Asthma
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 26 Apr 2016 Results published in the Allergy
    • 28 Feb 2012 Planned end date changed from 1 Jul 2012 to 1 Mar 2014 as reported by University Hospital Medical Information Network - Japan record.
    • 20 Feb 2012 Additional lead trial investigator (Matsumoto H) identified as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top